Search results
Vertex (NASDAQ:VERX) Price Target Cut to $32.00
ETF DAILY NEWS· 7 hours agoA number of other research firms have also issued reports on VERX. The Goldman Sachs Group raised their price target on shares of Vertex from $33.00 to $39.00 and gave the ...
Vertex (NASDAQ:VERX) Shares Gap Down on Analyst Downgrade
ETF DAILY NEWS· 9 hours agoShares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) gapped down prior to trading on Tuesday after Citigroup lowered their price target on the stock from $34.00 to $32.00 ...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoAnd just recently, it made two big moves that could advance its position in other high-potential...
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 3 days agoIf you'd invested $10,000 in Vertex five years ago, you would have accompanied the company on some...
Brokers Set Expectations for Vertex Pharmaceuticals Incorporated’s Q3 2025 Earnings (NASDAQ:VRTX)
ETF DAILY NEWS· 1 day agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Vertex ...
Vertex (NASDAQ:VERX) Given “Market Outperform” Rating at JMP Securities
ETF DAILY NEWS· 1 day agoJMP Securities reaffirmed their market outperform rating on shares of Vertex (NASDAQ:VERX – Free Report) in a research report released on Tuesday morning, Benzinga reports ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lessened by Hussman Strategic...
ETF DAILY NEWS· 3 days agoHussman Strategic Advisors Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 59.6% during the fourth quarter, according ...
Arc’teryx Vertex Alpine GTX approach shoe review: style and performance on above-the-treeline...
Advnture via Yahoo News· 7 days agoI did find that the sole pattern collected some mud when I got lower down, but again, that’s because...
Vertex inches closer to acute pain market with FDA application acceptance
FierceBiotech· 7 days agoVertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain...
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Raised to $450.00
ETF DAILY NEWS· 5 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price lifted by equities research analysts at Guggenheim from $445.00 to $450.00 in a research note issued ...
